John Aballi Net Worth & Insider Trades

John Aballi - President and CEO, Exagen Inc

As of October 18, 2023

What is John Aballi's Net Worth?

The current estimated net worth of Exagen Inc's President and CEO, John Aballi, is estimated to be about $783.52K . John Aballi owns about 415,984 units of Exagen Inc common stock. In the last year at Exagen Inc, John Aballi has sold an estimated value of $59.02K worth.

What is John Aballi's Past Insider Trading?

John Aballi's largest purchase order was 90,000 units , worth over $241.2K on December 9, 2022. John Aballi's largest sale order was 33,819 units , worth over $59.02K on October 18, 2023. In total, John Aballi has made about 4 transactions over a year of their time at Exagen Inc. John Aballi usually trades in October, with the busiest year in 2022 and 2023.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is John Aballi's' Mailing Address?

  • Mailing address is C/o Decipher Biosciences, Inc. 6925 Lusk Blvd, Suite 200 San Diego CA 92121 CA

Exagen Inc Executive Compensation

Name
Year
Salary
Bonus
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Fortunato Ron Rocca 2020 $499,733 - $1,742,603 $566,799 $8,550 $2,817,685
Fortunato Ron Rocca 2019 $358,195 $73,875 $1,082,039 $105,216 $8,400 $1,627,725
Kamal Adawi 2020 $381,170 - $590,237 $230,580 $8,550 $1,210,537
Kamal Adawi 2019 $278,110 $28,679 $168,831 $40,846 $8,400 $524,866
Debra Zack, M.D., Ph.D. 2020 $296,692 - $633,440 $185,617 $6,533 $1,122,282
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1274737/000127473721000032/a2021def14a.htm

What are Exagen Inc's Past Insider Trades?

Exagen Inc's most recent insider trade came on October 18, 2023 by John Aballi who sold 33,819 units worth $59.02K . In the last 4 years, insiders at Exagen Inc have sold an estimated value of $10.57M and bought an estimated value of $8.11M worth of shares. Insider trading is most common in June, with the busiest year in 2020. The most active traders at the company are James Tullis,  Kamal Adawi, CFO and Corporate Secretary,  and Ebetuel Pallares, Director .

EXAGEN INC. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...